This abstract, "Use of Natural Language Processing to Augment Real-World Data (RWD) and Identify Eligible Patients at Scale for Oncology Studies", originally presented at ISPOR 2024 earlier this year, examines the rich and previously untapped potential of unstructured data within electronic health records (EHRs). Read the full abstract, co-written in part by Avi R., Jess Paulus, Zhaohui Su, Genc Doko, and Nicholas Robert today: https://lnkd.in/gVvFSHCC #ISPOR2024 #Cancer #RWE #Health #Medical
关于我们
We are an oncology data, research and technology business dedicated to improving the lives of patients and transforming the fight against cancer.
- 网站
-
https://www.ontada.com
Ontada的外部链接
- 所属行业
- 科技、信息和网络
- 规模
- 501-1,000 人
- 总部
- Boston,MA
- 类型
- 上市公司
- 领域
- synthetic controls、pragmatic trials、trial optimization、market access studies、medical affairs studies、provider technology、EHR、EMR、data feeds、oncology、Real world data、Real world research、Patient Education、Clinical education、real world evidence、Cancer、oncology research、oncology development和oncology commercialization
地点
-
主要
33 Arch St
US,MA,Boston,02110
Ontada员工
动态
-
We're so excited to be attending the DIA 2024 Real-World Evidence Conference next week in Philadelphia, PA! To those planning on being at the event, be sure to swing by the Ontada booth at Exhibit Table #12 and say hello! For more information and to register for the event, visit the DIA Global website today: https://lnkd.in/gFUEHAN7 #RWE24 #RWE #Healthcare #Oncology #Cancer
-
In this article from Current Oncology, patients exhibiting non-specific signs and/or symptoms (NSSS) of cancer were studied in an effort to better identify unmet needs and potential areas of improvement for diagnostic tools in cancer treatment and research. Authors include Karen Todoroff and Dr. Ira Zackon from Ontada. Read the full article today: https://lnkd.in/g-gKr3hz #Oncology #RWD #RWE #Healthcare #Medical
-
Ontada转发了
Don't miss the 21st Annual Society for Melanoma Research Congress this weekend in New Orleans, LA! For those attending, be sure to check out our poster presentation, "Concordance of real-world and clinical trial survival endpoints in early-stage melanoma." #SMR2024 #Presentation #Oncology #Dermatology #ThoughtLeadership
-
ICYMI: At this year's Society of Hematologic Oncology Annual Meeting, we presented the poster "Recent Patterns of Care With BTK Inhibitors and Distribution of Social Determinants of Health Among Patients With CLL/SLL in the US Community Setting." This study examined characteristics, treatment patterns, and social determinants of health (SDOH) of BTK inhibitor–treated patients with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) in a community practice network. Read the full article, co-written by Ontada's own Kat Aguilar, Chuck Wentworth, Yunfei Wang, and Ira Zackon, MD: https://lnkd.in/gGfJ3Kqk #Cancer #RWD #RWE #Hematology
-
Don't miss the 21st Annual Society for Melanoma Research Congress this weekend in New Orleans, LA! For those attending, be sure to check out our poster presentation, "Concordance of real-world and clinical trial survival endpoints in early-stage melanoma." #SMR2024 #Presentation #Oncology #Dermatology #ThoughtLeadership
-
NEW: In this whitepaper, we explore the growing importance of community biomarker data in cancer research/treatment, as well as the applications that this data could have in informing oncology brand strategy and management. Download the free whitepaper on our website: https://lnkd.in/gtian4kC #RWD #RWE #Marketing
-
Wanmei Ou, Ontada’s VP of Product, Data Analytics and AI shared her thoughts on the latest advancements in AI and its impact on the healthcare industry at this week’s Microsoft AI Tour in Boston. She spoke to the future and next big breakthroughs of Generative AI in Healthcare, and the barriers to its implementation, including privacy, security and ethical considerations. #Oncology?#AI?#HealthcareInnovation
-
October is Breast Cancer Awareness Month. In this research article, co-authors Nicholas Robert, Kat Aguilar, and Yunfei Wang from Ontada explore the efficacy of palbociclib plus aromatase inhibitor in the treatment of metastatic breast cancer. Read the full article, "Real-world comparative effectiveness of palbociclib plus aromatase inhibitor in HR+/HER2 - metastatic breast cancer," at the link below: https://lnkd.in/gCPEGprW #Oncology #RWD #RWE #CancerTrials
-
In Volume 2 of our "Oncology Real-World Data and Research: 12 Oncology Research Studies" booklet, we examine the potential of leveraging real-world data to generate impactful insights, provide evidence for label expansion or line of therapy changes, and more. Read the full booklet at the link below: https://lnkd.in/gmmhYtba #Cancer #RWD #Healthcare